Hsiang, David J <br/><br/>
Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.  [electronic resource] 

 -  Archives of surgery (Chicago, Ill. : 1960)  Sep 2007 
 - 855-61; discussion 860-1 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-0010 
<br/><br/><label>Standard No.: </label>10.1001/archsurg.142.9.855  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Axilla<br/>Breast Neoplasms--drug therapy<br/>Carboplatin--administration & dosage<br/>Contrast Media<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Gadolinium DTPA<br/>Humans<br/>Lymph Node Excision<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Magnetic Resonance Imaging--methods<br/>Mastectomy<br/>Mastectomy, Segmental<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Paclitaxel--administration & dosage<br/>Predictive Value of Tests<br/>Receptor, ErbB-2--analysis<br/>Retrospective Studies<br/>Sensitivity and Specificity<br/>Trastuzumab<br/>Treatment Outcome